Skip to content
MARKETS / NYSE / UNH
NYSE · HOSPITAL & MEDICAL SERVICE PLANS · LARGE CAP

Unitedhealth Group Inc. UNH

19 fiscal years on record · USD · FY2025 reported · SEC filings only
16 YEARS OF DIVIDEND GROWTH
$447.6B
▲ 11.8% YoY
$12.1B
▼ 16.3% YoY
$16.1B
▼ 22.4% YoY
In brief

What this company does

UnitedHealth Group operates in markets across health care benefits and health care services. As of December 31, 2025, it had more than 390,000 employees, of whom nearly 165,000 were clinical professionals. Premium revenues from the Centers for Medicare & Medicaid Services represented 44% of total consolidated revenues for the year ended December 31, 2025. It reports four segments: Optum Health, Optum Insight, Optum Rx and UnitedHealthcare, the last of which takes in the Employer & Individual, Medicare & Retirement and Community & State businesses. Optum Health delivers care addressing the physical, mental, social and financial well-being of 95 million consumers and serves more than 100 health payer partners. Optum Insight offers data, analytics, research, consulting, technology and managed services solutions. Optum Rx provides pharmacy care services through a network of approximately 64,000 retail pharmacies, through home delivery, specialty and community health pharmacies, and through in-home and community-based infusion services. As of December 31, 2025, UnitedHealthcare enrolled 10.4 million people in the Medicare Part D programs, including 2.8 million individuals in stand-alone Medicare Part D plans.

Written from the business description in UNITEDHEALTH GROUP INC's annual report to the U.S. Securities and Exchange Commission, filed 2 March 2026. Every sentence was checked against that document before publication.

Growth
USD 447.6B
Revenue, FY2025 · full 19-year series below
Revenue $B Net income $B
FY2025 · Revenue 447.6 · Net income 12.1
200B400B2007201020132016201920222025
Compound annual growth
+11.4%
+11.7%
+11.0%
+11.0%
−15.7%
−4.8%
+7.6%
+6.6%
−14.5%
−3.8%
+8.2%
+8.1%
+10.9%
+12.6%
+16.6%
+22.7%
+2.5%
+11.3%
+17.2%
+10.9%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +11.7% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
3 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 4.2% · Net 2.9%
5%10%2007201020132016201920222025
ROE
FY2015 · ROE 17.9%
10%20%2007201020132016201920222025

Cash & shareholders
USD 12.6B
returned in FY2025 · dividends + net buybacks
Free cash flow $B
FY2025 · FCF 16.1
10B20B2007201020132016201920222025
Net buybacks $B Dividends $B
FY2025 · Dividends 7.9 · Net buybacks 4.7
5B10BDividendsNet buybacks2007201020132016201920222025

USD 7.9B in dividends and USD 4.7B in buybacks — 105% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 309.6B
CashUSD 24.4B
Gross debtUSD 78.4B
Net debtUSD 54.0B
Current ratio0.79×

Not available: we don't have the shareholders' equity figure for this period.

The 19-year record
19 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 2025202420232022202120202019201820172016201520142013201220112010200920082007
Revenue $B447.6400.3371.6324.2287.6257.1242.2226.2201.2184.8157.1130.5122.5110.6101.994.287.181.275.4
Operating income $B19.032.332.428.424.022.419.717.315.212.911.010.39.69.38.57.96.45.37.8
EBITDA $B20.033.333.529.525.023.420.718.316.013.611.610.810.19.78.88.36.8··
Income tax $B1.94.86.05.74.65.03.73.63.24.84.44.03.23.12.82.72.01.62.7
Net income $B12.114.422.420.117.315.413.812.010.67.05.85.65.65.55.14.63.83.04.7
Free cash flow $B16.120.725.723.419.920.116.413.711.68.18.26.55.76.15.95.44.93.45.0
EPS, diluted $13.2315.5123.8621.1818.0816.0314.3312.1910.727.256.015.705.505.284.734.103.242.403.42
Dividend / sh $8.738.187.296.405.604.834.143.452.882.381.881.411.050.800.610.410.030.030.03
Payout %66523030313028282632312419151310111
ROE %··········17.917.417.818.619.018.717.214.623.2
Shares out B0.910.920.920.930.940.950.950.960.970.950.950.950.991.021.041.091.151.20·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Compare

This company against its peers

Provenance
Company facts, as filed
How we verify · 0 failures in 74 reconciliationsAUDITED

Reconciled in 19 of 19 fiscal years. 2 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityHospital & Medical Service Plans
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2007

Share this section

Download image